California Cancer Reporting System Standards, Volume III

TNM Path T

IDENTIFIERS

OWNER

AJCC

DESCRIPTION

Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of surgical therapy.

LEVEL

Tumors, Admissions

LENGTH

4

ALLOWABLE VALUES

er125 TNM Path T

Codes in addition to those published in the AJCC Cancer Stating Manual:

Note: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM elements and stage groups.  See the FORDS manual for specifications for codes and data entry rules.

SOURCE

If Coding Procedure is less than 33, then

1. Execute the same conversions from use case Perform Eureka 2016 One-Time Data Conversions and Table Populations – UC, step 3, for the new admission.

UPDATE

TNM Path Fields Update Logic

CONSOLIDATED DATA EXTRACT

Yes

To choose the proper values to submit to the State, the fields must be grouped into meaningful clusters, in which all the fields must come from the same report. Therefore, the following groups:

• the first T,N,M, and AJCSTAGE, for clinically-based staging
• the second T,N,M, and AJCSTAGE, for pathologic-based staging

For each group listed above, start with the most recent (i.e., latest admission date) analytic admission (class of case =10-22) and work back, until an admission is found with all non-blank values in the group (no item in the group is missing). In other words, only send values when they are non-blank for all variables considered in the group. However, if there is no qualifying analytic group send the values from the most recent non-blank, non-analytic admission.

The only exception to the above rule is if no TNM is found by that method, but there is an AJCC Stage, then send in the AJCC Stage from the latest analytic admission.

INTERFIELD EDITS

IF1129:TNM Edition Number, TNM Fields

IF1134: Primary Site, AJCC T-Ed 7, ICDO3

IF1164: Primary Site, T 2016 – Ed 7, ICDO3

IF1167: Primary Site, TNM Path Stage Valid A – Ed 7 (COC)

IF1187: TNM Groups Not Stageable - Insitu (COC)  

IF1209: TNM Path T, Depth, Melanoma – Ed 7, ICDO3 (COC)

IF1210: TNM Path T, Primary Site, Surgery – Ed 7 (COC)

IF1215: TNM Path T, SSF 3 Prostate (COC)

IF1217: TNM T, Breast, Inflam Carcinoma (COC)

IF1218: TNM T, Clin and Path Stage, Behavior 2 (COC)

IF1219: TNM T, Clin and Path Stage, Behavior 3 (COC)

IF1220: TNM T, Deep Sites Soft Tissue (COC)

IF1221: TNM T, Descriptor, SSF 1 Thyroid (COC)

IF1123 Primary Site (Prostate), Histologic Type ICD-O-3

IF1224: TNM T, Size, Uveal Melanoma (COC)

IF1225: TNM T, SSF 1 Conjuctiva (COC)

IF1226: TNM T, SSF 1, 2 Lung (COC)

IF1227: TNM T, SSF 10 Bile Ducts Intrahepatic (COC)

IF1228: TNM T, SSF 12, Tumor Size, Carcinoma of Skin (COC)

IF1229: TNM T, SSF 6 Skin of Eyelid (COC)

IF1230: TNM T, SSF 6, Breast (COC)

IF1231: TNM T, Size, Site Spec – Ed 7, ICDO3 (COC)

IF1238: Tumor Size Pathologic, TNM Path T (SEER)

IF1241: Tumor Size Summary, TNM Clin/Path T (COC)

IF1242: TNM Groups Beh 3 with Insitu 88 (COC)

HISTORICAL CHANGES